SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001651308-20-000078
Filing Date
2020-06-19
Accepted
2020-06-19 16:17:13
Documents
1
Period of Report
2020-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_159259781429439.html 4  
1 FORM 4 wf-form4_159259781429439.xml 4 4537
  Complete submission text file 0001651308-20-000078.txt   6003
Mailing Address C/O KINIKSA PHARMACEUTICALS, LTD. CLARENDON HOUSE, 2 CHURCH STREET HAMILTON D0 HM11
Business Address
Malley Thomas (Reporting) CIK: 0001403322 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37686 | Film No.: 20975844

Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Issuer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations